Diphtheria Tetanus and Pertussis (DPT) Vaccine Market 7.3% CAGR Showing Vigorous Growth to 2027 -Merck & Co., Sanofi, Serum Institute of India Pvt. Ltd., and Wyeth, etc

The global DPT vaccine market has been segmented on the basis of application, type, and lastly region. As per the application-based segmentation, this market has been segmented into diphtheria, pertussis, and tetanus. Diphtheria is a serious bacterial infection. It affects the mucous membranes of the throat and nose. Pertussis is a highly contagious respiratory disease, commonly known as whooping cough. Tetanus is an infection characterized by muscle spasms. By types, the market has been segmented into DPaT, DTwP, and Tdap.

DPT vaccine stands for Diphtheria Tetanus and Pertussis Vaccine. Market Research Future (MRFR) has published a research report about the global DPT vaccine market that predicts significant growth with 7.3% CAGR (Compound Annual Growth Rate) for this market between 2016 and 2027. The key factors that drive this market include increasing awareness for DPT vaccines and increasing deaths in children due to pertussis.

Observing the market structure, this report evaluates the future growth potential of the market and analyzes the strategies of the key players in the market. It also follows the competitive developments such as joint ventures, new product developments, mergers and acquisitions, research & developments (R & D) in the market.

Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1357

Key Players for Global Diphtheria Tetanus and Pertussis (DPT) Vaccine Market

The key players in the global DPT vaccine market include Chiron Pharmaceutical Pvt Ltd (India), GSK (USA), Institute of Biological Products (China), Lanzhou Institute of Biological Products (China), Merck & Co., Inc (USA), Sanofi (France), Serum Institute of India Pvt. Ltd. (India), and Wyeth (USA).

Latest Industry News

The Lee County Health Department recently organized a vaccination drive for children that included vaccines against DTP, hepatitis B, measles, mumps and rubella (MMR), polio (IPV), and varicella (chickenpox). 20 JUL 2018
Various vaccination shots including DPT vaccines were offered to various uninsured and underinsured children for free in Las Vegas. 15 JUL 2018
Global DPT vaccine Market - Company Analysis

Merck: Merck provides a wide range of vaccines which includes BCG USP, Pneumonix, Varivax, Pedvax HIB, Recombivax HB and others.

Sanofi: Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, consumer healthcare, established prescription products and generics. Diphtheria and Tetanus Toxoids and acellular Pertussis Vaccine called Daptacel is the product offered by Sanofi which is the major market player.

Regional Analysis for Global Diphtheria Tetanus and Pertussis (DPT) Vaccine Market

The regional segmentation of the global DPT vaccine market segments the market into regional markets namely North America, Europe, Asia Pacific, and the Middle East & Africa (MEA). According to the report, the North American market, which is currently the largest regional market, is expected to grow steadily over the forecast period due to most advanced medical facilities and government aided grants for R & D with emphasis on vaccination against DPT being available in the United States of America (USA) and many key players in this region having bases of operations here. After the USA, most significant country-based markets in this region are Canada and Mexico.

Europe, the second largest market for DPT Vaccine, is expected to grow overwhelmingly during the forecast period. Factors that drive the market growth in this region include increasing R & D activities by pharmaceutical companies and research institutes, the presence of key market players, increasing awareness about immunization of children against DPT. In Europe, most key players are based in strong economies like the United Kingdom (UK) and France.

The report estimates the Asia Pacific to emerge as the fastest market during the forecast period. In this region, India as a market is likely to rise with incredible speed. Here, the market growth is due to factors like growth in the prevalence of infectious disease, increase in adoption of vaccination, and rapid population growth. Governments in many Asia Pacific countries are undertaking various vaccinations programs. During the forecast period, the market in the MEA region shows steady growth. In this region, the demand for DPT vaccine is less than other regions. The market is low due to lack of awareness, lack of education, lack of technological development, political instability, poor healthcare, and healthcare not considered a priority by most governments.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/dpt-vaccine-market-1357

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.